Penumbra targets 13%-14% revenue growth for 2025 with focus on thrombectomy market expansion Penumbra targets 13%-14% revenue growth for 2025 with focus on thrombectomy market expansion Post ContentpenRead More You might also be interested in reading To IPO or Not to IPO? SPAC is the question. February 19, 2025 In Mainstream ← Previous post Next post →